Approvals/CIMA-AEMPS/BORTEZOMIB FRESENIUS KABI 2,5 mg POLVO PARA SOLUCION INYECTABLE EFG

Approved

STANDARD

BORTEZOMIB FRESENIUS KABI 2,5 mg POLVO PARA SOLUCION INYECTABLE EFG

Fresenius Kabi Deutschland Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 8ff2c24539cc52f8
Drug Cima Aemps Name: BORTEZOMIB FRESENIUS KABI 2,5 mg POLVO PARA SOLUCION INYECTABLE EFG
Register Number: 1191397003
Holder Company Name: Fresenius Kabi Deutschland Gmbh
Marketing Company Name: Fresenius Kabi España, S.A.U.
Holder Company Detail Path: /organization/fresenius-kabi-deutschland-gmbh
Authorization Date: 2021-06-23
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE
Dose: 2.5 mg
Route Of Administration: VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Fresenius Kabi Deutschland Gmbh
Company Detail Path: /organization/fresenius-kabi-deutschland-gmbh

BORTEZOMIB

2,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 23, 2021

Approval ID

8ff2c24539cc52f8

Type

Standard